Eralda Hegendörfer

Eralda Hegendörfer

Auto-generated profile, based on publicly available information

Eralda Hegendörfer

Belgian Health Care Knowledge Centre (KCE)

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
EHEralda Hegendörfer
Eralda Hegendörfer
BVBert Vaes
Bert Vaes
EAElena Andreeva
Elena Andreeva
CMCatharina Matheï
Catharina Matheï
GPGijs Van Pottelbergh
Gijs Van Pottelbergh
JDJean-Marie Degryse
Jean-Marie Degryse

5 August 2016 in Aging Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
ATAnna Turusheva
Anna Turusheva
EFElena Frolova
Elena Frolova
EHEralda Hegendoerfer
Eralda Hegendoerfer
JDJean-Marie Degryse
Jean-Marie Degryse

14 June 2017 in Age and Ageing
Verified
Journal Article
Closed access
PDF file
EHEralda Hegendörfer
Eralda Hegendörfer
BVBert Vaes
Bert Vaes
CMCatharina Matheï
Catharina Matheï
GPGijs Van Pottelbergh
Gijs Van Pottelbergh
JDJean-Marie Degryse
Jean-Marie Degryse
Adults aged 80 and over, a fast growing age-group, with increased co-morbidity and frailty have not been the focus of previous research on dyspnoea. We investigate the correlates of dyspnoea and its association with adverse outcomes in a cohort of adults aged 80 and over. about 565 community-dwelling adults aged 80 and over of the BELFRAIL prospective cohort had assessment of Medical Research Council dyspnoea scale (MRC), forced expiratory volume in 1 s (FEV1), N-terminal pro-brain natriuretic peptide (NT-proBNP), physical performance tests, grip strength, 15 items geriatric depression scale, activities of daily living (ADL), body mass index (BMI) and demographics data. Kaplan–Meier survival curves, Cox and logistic multivariable regression, classification and regression tree (CART) analysis assessed association of dyspnoea (MRC 3–5) with time-to-cardiovascular and all-cause death (5 years), time to first hospitalisation (3 years), new/worsened ADL disability (2 years), and its correlates. participants with dyspnoea MRC 3–5 (29.9%) had increased hazard ratios for cardiovascular mortality 2.85 (95% confidence interval 1.93–4.20), all-cause mortality 2.04 (1.58–2.64), first hospitalisation 1.72 (1.35–2.19); and increased odds ratio for new/worsened disability 2.49 (1.54–4.04), independent of age, sex and smoking status. Only FEV1, physical performance, BMI and NT-proBNP (in order of importance) were selected in the tree-based classification model for dyspnoea. in a cohort of adults aged 80 and over, dyspnoea was common and an independent predictor of adverse outcomes, with cardio-respiratory and physical performance impairments as key independent correlates. Its routine and comprehensive evaluation in primary care could be very valuable in caring for this age-group.

1 March 2020 in Journal of the American Medical Directors Association
Verified
Journal Article
Open access
EHEralda Hegendörfer
Eralda Hegendörfer
BVBert Vaes
Bert Vaes
GPGijs Van Pottelbergh
Gijs Van Pottelbergh
CMCatharina Matheï
Catharina Matheï
Jan VerbakelJan Verbakel
Jan Verbakel
JDJean-Marie Degryse
Jean-Marie Degryse
To compare the predictive performance of 3 frailty identification tools for mortality, hospitalization, and functional decline in adults aged ≥80 years using risk reclassification statistics and decision curve analysis. Population-based, prospective cohort. BELFRAIL study, Belgium. 560 community-dwelling adults aged ≥80 years. Frailty by Cardiovascular Health Study (CHS) phenotype, Longitudinal Aging Study Amsterdam (LASA) markers, and Groeningen Frailty Indicator (GFI); mortality until 5.1 ± 0.25 years from baseline and hospitalization until 3.0 ± 0.25 years; and functional status assessed by activities of daily living at baseline and after 1.7 ± 0.21 years. Frailty prevalence was 7.3% by CHS phenotype, 21.6% by LASA markers, and 22% by GFI. Participants determined to be frail by each tool had a significantly higher risk for all-cause mortality and first hospitalization. For functional decline, only frail by GFI had a higher adjusted odds ratio. Harrell 's C-statistic for mortality and hospitalization and area under receiver operating characteristic curve for functional decline were similar for all tools and <0.70. Reclassification statistics showed improvement only by LASA markers for hospitalization and mortality. In decision curve analysis, all tools had higher net benefit than the 2 default strategies of "treat all" and "treat none" for mortality risk ≥20%, hospitalization risk ≥35%, and functional decline probability ≥10%, but their curves overlapped across all relevant risk thresholds for these outcomes. In a cohort of adults aged ≥80 years, 3 frailty tools based on different conceptualizations and assessment sources had comparable but unsatisfactory discrimination for predicting mortality, hospitalization, and functional decline. All showed clinical utility for predicting these outcomes over relevant risk thresholds, but none was significantly superior. Future research on frailty tools should include a focus on the specific group of adults aged ≥80 years, and the predictive accuracy for adverse outcomes of different tools needs a comprehensive assessment that includes decision curve analysis.

5 March 2020 in Acta Clinica Belgica
Verified
Journal Article
Closed access
EHEralda Hegendörfer
Eralda Hegendörfer
VVVeronika VanAcker
Veronika VanAcker
BVBert Vaes
Bert Vaes
JDJean-Marie Degryse
Jean-Marie Degryse
Objectives: To investigate the prevalence of malnutrition risk and its association with adverse outcomes in a Belgian cohort of community-dwelling adults aged ≥80 years, a worldwide growing age-group. Methods: In the BELFRAIL cohort, malnutrition risk was evaluated with the Mini Nutritional Assessment (MNA total score <24) and prealbumin levels (<20 mg/dl). Agreement between them was assessed with Kohen’s kappa coefficient. Association with first unplanned hospitalization (3.0 ± 0.25 years follow-up) and mortality (5.1 ± 0.25 years follow-up) was investigated with survival analysis and Cox multivariate regression. Results: Out of 567 BELFRAIL participants, 556 (98.1%) had MNA and 545 (96.1%) prealbumin levels. Sixty-eight (12.2%) were at risk of malnutrition based on MNA and 69 (12.7%) based on prealbumin, with very poor agreement between them (Kappa = 0.024, 95% CI −0.064, 0.112). For both MNA and prealbumin, participants with malnutrition risk had lower physical and cognitive performance tests' scores. They had no higher risk for first hospitalization compared to those without malnutrition risk, but higher risk for all-cause mortality even after adjustment for multimorbidity, inflammation, physical and mental functioning (HR 1.35 95%CI 0.92–1.97 for MNA; HR 1.46; 95%CI 1.01–2.12 for prealbumin). Conclusion: Malnutrition risk based on MNA or prealbumin was low in a Belgian cohort of community-dwelling adults aged ≥80 years. Physical and cognitive performance was lower in those with malnutrition risk, but malnutrition risk was not independently associated with hospitalization and mortality (except for malnutrition risk by prealbumin). Further research needs to investigate the best tool to assess malnutrition risk in this age group.

6 November 2020 in ERJ Open Research
Verified
Journal Article
Open access
EHEralda Hegendörfer
Eralda Hegendörfer
ADAlexander Doukhopelnikoff
Alexander Doukhopelnikoff
JDJean-Marie Degryse
Jean-Marie Degryse
Breathlessness is a common and distressing symptom in older adults and an independent predictor of adverse outcomes and yet its multidimensional assessment has not been validated in older adults. We apply and validate the Multidimensional Dyspnoea Profile (MDP) in a sample of adults 75 years and older in Belgium.Breathlessness was rated with the MDP, the modified Borg Dyspnoea Scale (mBDS), the Short Physical Performance Battery (SPPB, a numerical rating scale for intensity and unpleasantness both before and after exertion), as well as with the Medical Research Council (MRC) Dyspnoea Scale. The Hospital Anxiety and Depression Scale (HADS) assessed the affective status. Factor structure was analysed with exploratory principal components analysis, internal consistency with Cronbach's alpha and concurrent validity with Spearman's correlation coefficients with other breathlessness scales, HADS and SPPB scores.In 96 participants (mean age 85 years; 34% men) who rated breathlessness at both assessment points, exploratory principal components analysis identified two components: Immediate Perception (IP) and Emotional Reaction (ER), explaining most of the MDP item variance (65.37% before and 71.32% after exertion). Internal consistency was moderate to high for MDP-IP (Cronbach's alpha = 0.86 before and 0.89 after exertion) and MDP-ER (Cronbach's alpha = 0.89 before and 0.91 after exertion). The correlation patterns of MDP-IP and MDP-ER with other tests confirmed concurrent validity.The domain structure, reliability and concurrent validity of MDP for breathlessness before and after exertion were confirmed in a sample of adults 75 years and older, supporting its use and further research for the multidimensional profiling of breathlessness in older adults.